Your browser does not support JavaScript or it may be disabled!
rediff.com
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
NEWS ON MOBILE
Get Realtime News
on your webpage

About 70 results for "Qualitest Pharmaceuticals"

Imprimis Pharmaceuticals Strengthens Senior Leadership Team with Key Hires in Operations, Quality, Manufacturing..
ADVFN India

Imprimis Pharmaceuticals Strengthens Senior Leadership Team wi...

SAN DIEGO, Aug. 15, 2016 /PRNewswire/ -- Imprimis Pharmaceuticals, Inc. (NASDAQ: IMMY), a pharmaceutical company dedicated to making drugs affordable again through its Branded Compounding(TM) business model, today reported the expansion of its ... 4 Traders, 1 month ago
[x]  

2 images for "Qualitest Pharmaceuticals"

BioSpace, 2 months ago
Attorney General: Idaho, 8 months ago

Imprimis Pharmaceuticals Adds to Senior Leadership Team with Hires in Operations, Quality, Manufacturing and Client Relations

Imprimis Pharmaceuticals has reported the expansion of its leadership team with the appointments ofClayton Edwardsas Senior Vice President of Operations,Eric Riceas Vice President of Client Relations,Pramod Sharma, PhD as Vice President of Quality, ...
 American Pharmaceutical Review1 month ago

Actinium Enhances Capabilities with Hiring of Industry and Clinical Research Veterans to its Product Development and Clinical Development Teams

Actinium Pharmaceuticals, Inc. (NYSE MKT:ATNM) ("Actinium" or "the Company"), a biopharmaceutical Company developing innovative targeted payload immunotherapeutics for the treatment of advanced cancers, announced today that it has added two industry ...
 International Business Times2 weeks ago ACTINIUM PHARMACEUTICALS : Enhances Capabilities with Hiring of Industry and Clinical Research Veterans to its Product Development and Clinical Development Teams  4 Traders2 weeks ago
[x]  
Federal Register

ALJ McNamara Sets Procedural Schedule In Certain Potassium Chloride Powder Products (337-TA-1013)

ALJ MaryJoan McNamara issued Order No. 5 in Certain Potassium Chloride Powder Products (Inv. No. 337-TA-1013). By way of background, this investigation is based on a complaint filed by Lehigh Valley Technologies, Inc., Endo Global Ventures, ...
 Lexology2 weeks ago ITC Institutes Investigation (337-TA-1013) Regarding Certain Potassium Chloride Powder Products  Lexology1 month ago Certain Potassium Chloride Powder Products; Institution of Investigation  Federal Register2 months ago Potassium Chloride Powder Products  United States International Trade Commission2 months ago

Propranolol Hydrochloride Tablets

Propranolol oral tablet, Global 10 mg, 1000 count (NDC 50111-0467-03) 80 mg, 500 count (NDC 50111-0471-02) Propranolol oral tablet, Major 10 mg, unit-dose 100 count (NDC 00904-0411-61) - discontinued Reason for the Shortage Actavis has ...
 ASHP2 weeks ago

People Continue to Complain About Generic Ambien…

We have received so many complaints about generic Ambien that we have lost count. We notified the FDA years ago about this problem but so far there seems to be no interest in finding out what the problems are. Here are some readers who are ...
 Peoples Pharmacy1 month ago

Endo International Plc (ENDP) Rajiv De Silva on Q2 2016 Results - Earnings Call Transcript

Endo International Plc (NASDAQ: ENDP ) Q2 2016 Earnings Call August 08, 2016 4:30 pm ET Executives Keri P. Mattox - Senior Vice President, Investor Relations & Corporate Affairs Rajiv De Silva - President, Chief Executive Officer & ...
 Seeking Alpha1 month ago Endo Reports Second Quarter 2016 Financial Results  Minyanville1 month ago Endo International plc ( ENDP )  Stock Junction1 month ago Earnings in Focus: Endo International plc (NASDAQ:ENDP)  Markets Daily2 months ago
[x]  
Nasdaq

Endo International: Not A Valeant Effort

Introduction Endo International (NASDAQ: ENDP ) is a hybrid generic and branded drug company with a roughly 60/40 revenue split between generic and branded pharmaceuticals. Both businesses have various challenges but in the current negative ...
 Seeking Alpha1 month ago Weitz Funds Comments on Endo International  Yahoo! Finance2 months ago

Weitz Value Fund Q2'16 Commentary: Hurt By Liberty Global, Endo, Allergan

By VW Staff Weitz Value Fund commentary for the second quarter ended June 30, 2016. The Weitz Value Fund's Institutional Class returned -0.41% in the second calendar quarter, compared to +2.46% for the S&P 500 and +2.54% for the Russell 1000.
 Seeking Alpha1 month ago Weitz Value Fund 2Q16 Commentary: Hurt By Liberty Global, Endo, Allergan  News EasyBranches.com1 month ago
Guru Focus

Weitz Funds' 2nd Quarter 2016 Value Fund Commentary

- By Holly LaFon The Value Fund's Institutional Class returned -0.41% in the second calendar quarter, compared to +2.46% for the S&P 500 and +2.54% for the Russell 1000. For the calendar year to date, the Value Fund's Institutional Class ...
 Yahoo! Finance2 months ago Weitz Funds' —nd Quarter —…6 Value Fund Commentary  Guru Focus2 months ago
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
1.
2.
3.
4.
5.
6.
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts

Get

Realtime News

on your Webpage

Add Widget >Get your members hooked!
    
Alerts
Get updated on latest news & your favorite topics right in your inbox!
 
More     Less